Check out the companies making headlines in midday trading. Sarepta Therapeutics — Shares of the biopharma company surged 33% after the U.S. Food and Drug Administration approved the expanded use of the company's gene therapy Elevidys for Duchenne muscular dystrophy. The FDA granted traditional approval of the therapy for patients 4 years and older who are able to walk and also granted accelerated approval for those who can't.
Gilead Sciences — Shares of the pharmaceutical company popped around 2%, adding to an 8.5% rally from the previous session. Gilead announced on Thursday that its twice-per-year shot preventing HIV was 100% effective in a late-stage trial . LendingTree — Shares declined 2.4% on the back of a Bloomberg report that hackers are auctioning off stolen consumer data from the online lending platform. LendingTree was the victim of a cyberattack against cloud computing firm Snowflake.